CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...

Your liver could be years older than you think, and you may not feel a thing. More than 110 million Americans have liver disease, estimates suggest - that's a four-fold surge from the 1980s. But most ...

Most of us don’t think about our liver at all. Not when we wake up. Not when we eat. Not even when we’re stressed about work or money. The heart gets all the attention. So do the lungs, the brain, ...

Google appears to have removed its AI-generated summaries for certain liver-related health searches after concerns were raised about the accuracy of the responses, TechCrunch reported Jan. 11. The ...

Google has quietly removed AI Overviews for liver test queries after they were found to give incorrect medical advice. An investigation found the feature gave oversimplified liver test ranges without ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

The FDA has halted clinical testing of an Intellia Therapeutics gene-editing therapy following a report that a patient in a Phase 3 study was hospitalized with liver complications. Intellia said the ...